Loading company…
Medizen Humancare provides genomic analysis and customized services for predicting and managing health risks.
Founded in 2012 and based in Seoul, Medizen Humancare provides genetic disease prediction and customized healthcare services. Its products include M-CHECK genomic analysis kits and the MELTHY (DTC) DNA analysis service, and it serves hospitals and medical institutions in South Korea and China. In May 2020, Daedeok Venture Partners and Korea Investment Partners acquired 90,624 shares at KRW 16,000 apiece for KRW 1.45 billion in a PIPE deal.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in